drugset / Trial / NCT02169804
An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal
Non-randomizedParallel-groupOpen-labelTreatment
Summary
• To determine and compare the pharmacokinetics (PK) of 3 doses of 25 mg Androxal in elderly healthy adult male subjects.
Timeline
- Start
- 2014-08
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Androxal | Unknown | 25 mg | — |
Indications
No indication recorded.